The influence of pre-anaesthetic administration of buprenorphine on the anaesthetic effects of ketamine/medetomidine and pentobarbitone in rats and the consequences of repeated anaesthesia

Laboratory Animals

Volumn 33, Issue 3, 1999, Pages 234-242

  Roughan, J V ^a   Burzaco Ojeda, O ^b   Flecknell, P A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Anaesthesia; Analgesia; Buprenorphine; Ketamine; Medetomidine; Pentobarbitone; Rat

Indexed keywords

ATIPAMEZOLE; BUPRENORPHINE; KETAMINE; MEDETOMIDINE; PENTOBARBITAL;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENERAL ANESTHESIA; LUNG EDEMA; MALE; MORTALITY; NONHUMAN; PREMEDICATION; RAT; RESPIRATION DEPRESSION; SLEEP TIME; STATISTICAL ANALYSIS;

ANIMALIA;

EID: 0032817155     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/002367799780578183     Document Type: Article

References (19)

1. DeWildt DJ, Hillen FC, Rauws AG, Sangster B (1983) Etomidate anaesthesia with and without fentanyl compared with urethane anaesthesia in the rat. British Journal of Pharmacology 79, 461-9
2. Field KJ, White WJ, Lang CM (1993) Anaesthetic effects of chloral hydrate, pentobarbitone and urethane in adult male rats. Laboratory Animals 27, 258-69
3. Flecknell PA, Kirk AJB, Fox CE, Dark JH (1990) Longterm anaesthesia with propofol and alfentanil in the dog and its partial reversal with nalbuphine. Journal of the Association of Veterinary Anaesthetists 17, 11-16
4. 2-adrenergic receptor agonist medetomidine in clinically normal cats anesthetized with isoflurane. American Journal of Veterinary Research 59, 509-13
5. Hecker BRLC, DiFazio CA, Moscicki JC, Engle JS (1983) The decrease in the minimum alveolar anesthetic concentration produced by sufentanil in rats. Anaesthesia and Analgesia 62, 987-90
6. Hilton P, Major E (1986) Intravenous anaesthesia with propofol and alfentanil. The influence of age and weight. Anaesthesia 41, 640-3
7. Home Office Animals (Scientific Procedures) Act 1986 (1989) Code of Practice for the Housing and Care of Animals used in Scientific Procedures. London: HMSO
8. Kay BRG (1977) ICI.35858, a new intravenous induction agent. Acta Anaesthesiologica Belgica 4, 303-22
9. Kissin I, Kerr CR, Smith LR (1984) Morphine-halothane interaction in rats. Anaesthesiology 60, 553-61
10. Lascelles BD, Cripps PJ, Jones A, Waterman AE (1997) Post-operative central hypersensitivity and pain: the pre-emptive value pf pethidine for ovariohysterectomy. Pain 73, 461-71
11. Lascelles BD, Waterman AE, Cripps PJ, Livingston A, Henderson G (1995) Central sensitization as a result of surgical pain: investigation of the pre-emptive value of pethidine for ovariohysterectomy in the rat. Pain 62: 201-12
12. Liles JH, Flecknell PA (1994) A comparison of the effects of buprenorphine, carprofen and flunixin following laparotomy in rats. Journal of Veterinary Pharmacology and Therapeutics 17, 284-90
13. Lovell DP (1986) Variation in pentobarbitone sleeping time in mice. 1. Strain and sex differences. Laboratory Animals 20, 85-90
14. Michalot G, Girardet P, Grimbert F, Piasentin D, Stieglitz P (1980) 24-hour althesin-fentanyl anaesthesia in dogs. Time course of haemodynamic changes. British Journal of Anaesthesia 52, 19-22
15. Morris TH (1995) Antibiotic therapeutics in laboratory animals. Laboratory Animals 29, 16-36
16. Ohtani M, Kotaki H, Uchino K, Sawada Y, Iga T (1994) Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats. Drug Metabolism and Disposition 22, 2-7
17. Salonen JS (1989) Pharmacokinetics of medetomidine. Acta Veterinaria Scandinavica 85, 49-54
18. 2O balanced anaesthesia: comparison of plasma hormonal changes, early postoperative respiratory function and speed of postoperative recovery. Anaesthesia and Analgesia 62, 285
19. White PF, Marietta MP, Pudwill CR, Way WL, Trevor AJ (1976) Effects of halothane anesthesia on the biodisposition of ketamine in rats. Journal of Pharmacology and Experimental Therapeutics 196, 545-55